Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2011
05/24/2011US7947872 Nucleotide sequences involved in plant disease resistance
05/24/2011US7947836 Biosensor and method of detection of a DNA sequence
05/24/2011US7947820 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
05/24/2011US7947819 B-raf polynucleotides
05/24/2011US7947817 Nucleotide blocked with sugar compound; biosynthesis of nucleic acids
05/24/2011US7947810 Kits for diagnosing a hypophosphatemic disorder
05/24/2011US7947657 Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA)
05/24/2011US7947513 Sets and compositions pertaining to analyte determination
05/24/2011US7947509 Optoelectronic detection system
05/24/2011US7947506 Protein detection and quantitation using hydroxyquinolone dyes
05/24/2011US7947486 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
05/24/2011US7947483 Methods and organisms for the growth-coupled production of 1,4-butanediol
05/24/2011US7947481 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin
05/24/2011US7947479 Bardet-Biedl susceptibility gene and uses thereof
05/24/2011US7947476 Analytical method and kit
05/24/2011US7947470 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders
05/24/2011US7947469 Protein comprising receptor nucleotide sequences associated with viral binding and/or infection for use in prevention and treatment of viral and autoimmune diseases; viricides
05/24/2011US7947468 Methods
05/24/2011US7947467 Methods for monitoring pathological conditions in a female subject
05/24/2011US7947462 Methods for identifying Kremen polypeptide binding partners
05/24/2011US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof
05/24/2011US7947458 Placental human neurokinin B precursor
05/24/2011US7947457 selecting spermatid germ line genomes at least partially based on one or more genetic characteristics of the germ line genomes
05/24/2011US7947456 Assessing brain aneurysms
05/24/2011US7947455 System for genome selection
05/24/2011US7947454 Methods and apparatus for characterizing polynucleotides
05/24/2011US7947453 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
05/24/2011US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses
05/24/2011US7947451 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
05/24/2011US7947450 Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
05/24/2011US7947449 Methods of diagnosing pre-eclampsia or eclampsia
05/24/2011US7947448 Use of regulatory sequences for specific, transient expression in neuronal determined cells
05/24/2011US7947447 Method for generating aptamers with improved off-rates
05/24/2011US7947446 High throughput mutation screening methods and kits using a universalized approach—differential sequence fill-in (DSF)-enabled sequential adapter ligation and amplification
05/24/2011US7947445 Method of detecting DNA of Candida guilliermondii
05/24/2011US7947444 Leptin promoter polymorphisms and uses thereof
05/24/2011US7947443 DNA and RNA conformational switches as sensitive electronic sensors of analytes
05/24/2011US7947441 Molecular detection and quantification of Enterococci
05/24/2011US7947440 Method for determining the specific growth rate of a distinct cell population within a non-homogeneous system
05/24/2011US7947439 Detection of bovine viral diarrhea virus in tissue samples
05/24/2011US7947438 Using presence of viral gp48 polypeptide in follicles of cattle as diagnostic indicator of viral disease; veterinary medicine
05/24/2011US7947437 Methods for detecting organisms and enzymatic reactions using raman spectroscopy
05/24/2011US7947435 Neuronal regeneration material screening method by ex vivo model
05/24/2011US7947309 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
05/24/2011US7947281 Chimeric proteins that induce effects directed against viruses
05/24/2011US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection
05/24/2011US7947224 Using colorimetric analysis to determine concentration of cells
05/24/2011US7947222 Mobile communication terminal equipped with temperature compensation function for use in bio-information measurement
05/24/2011CA2725728A1 Differentiation of human embryonic and induced pluripotent stem cells
05/24/2011CA2507240C Multiplex assay detection of pathogenic organisms
05/24/2011CA2506159C Fat regulation
05/24/2011CA2453001C Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling
05/24/2011CA2450467C Methods for modulating bladder function
05/24/2011CA2445911C Methods for the identification of antiviral compounds
05/24/2011CA2402534C Mrna amplification
05/24/2011CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby
05/24/2011CA2374215C New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
05/24/2011CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
05/24/2011CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
05/24/2011CA2338751C Cancer cells from body fluids containing cells, isolation thereof and agents containing the same
05/24/2011CA2323072C Gfr.alpha.3 and its uses
05/24/2011CA2305800C Biosensor electrode mediators for regeneration of cofactors
05/24/2011CA2270913C Human tumor necrosis factor receptor-like 2
05/24/2011CA2266640C Methods for treating an ischemic disorder and improving stroke outcome
05/24/2011CA2214116C Novel endoglucanases
05/24/2011CA2211687C Vascular endothelial growth factor-b
05/24/2011CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
05/19/2011WO2011060380A1 Pik3ca mutation status and sash1 expression predicts synergy between lapatinib and an akt inhibitor in her2 positive breast cancer
05/19/2011WO2011060240A1 Copy number analysis of genetic locus
05/19/2011WO2011060040A1 Diagnostic and therapeutic applications of the u6 snrna
05/19/2011WO2011060014A1 Small rna detection assays
05/19/2011WO2011059895A1 Hexa mutations
05/19/2011WO2011059835A2 Wt1 mutations for prognosis of myeloproliferative disorders
05/19/2011WO2011059802A1 Rapid detection of mycoplasma contamination in cell culture samples
05/19/2011WO2011059730A2 Nucleic acid probes and methods for detecting plasmodium parasites
05/19/2011WO2011059490A1 Heart aging biomarkers and methods of use
05/19/2011WO2011059453A1 Methods for producing surface bound oligonucleotide on solid substrate and uses thereof
05/19/2011WO2011058993A1 Method for screening for novel bone resorption inhibitor
05/19/2011WO2011058765A1 Target gene for anti-cancer activity of tocotrienol, biomarker, and use of the biomarker
05/19/2011WO2011058721A1 Substrate with photo-controllable cell adhesion property, method for analyzing and fractionating cells, and device for analysis and fractionation of cells
05/19/2011WO2011058580A1 Oligonucleotides and process for detection of swine flu virus
05/19/2011WO2011058408A2 Recql4/recql4 variant-p53 complex for altered mitochondrial function in rothmund-thomson syndrome
05/19/2011WO2011058367A2 Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor
05/19/2011WO2011058232A1 Nutrigenetic biomarkers for obesity and type 2 diabetes
05/19/2011WO2011058164A1 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
05/19/2011WO2011058151A1 Group specific primers
05/19/2011WO2011058143A1 Signature for the diagnosis of breast cancer aggressiveness and genetic instability
05/19/2011WO2011058131A1 Methods of producing a bacterial preparation
05/19/2011WO2011058084A1 Biomarkers for predicting rapid response to hcv treatment
05/19/2011WO2011058065A1 Method and medium for detecting shiga toxin-producing escherichia coli bacteria
05/19/2011WO2011057683A1 Use of metastasis progressor s100a4 transcripts in body fluids of colorectal and gastric cancer patients
05/19/2011WO2011057487A1 Markers, methods, biochips and kits for milk qualit y detection
05/19/2011WO2011057467A1 Nucleic acid chip, preparation method and use thereof
05/19/2011WO2011057411A1 Ovarian markers of oocyte competency and uses thereof
05/19/2011WO2011057354A1 Epigenetic analysis
05/19/2011WO2011057347A1 Analyte detection
05/19/2011WO2011028826A3 Reversible current gel electrophoresis device for separating biological macromolecules
05/19/2011WO2011027966A3 Td probe and its uses
05/19/2011WO2011027332A3 Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereof
05/19/2011WO2011021177A3 Compositions and methods for prognosis and treatment of prostate cancer